CD3 limits the efficacy of TCR gene therapy in vivo.
Ahmadi M, King JW, Xue SA, Voisine C, Holler A, Wright GP, Waxman J, Morris E, Stauss HJ.
Ahmadi M, et al. Among authors: voisine c.
Blood. 2011 Sep 29;118(13):3528-37. doi: 10.1182/blood-2011-04-346338. Epub 2011 Jul 12.
Blood. 2011.
PMID: 21750319
Free article.